American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant therapy for melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance public workshop
    Review

    Mueller, K. L.; Theoret, M. R.; Lemery, S. J.; Amiri-Kordestani, L.; Ariyan, C. E.; Atkins, M. B.; Berry, D. A.; Blank, C. U.; DeMichele, A. M.; Forde, P. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors
    Journal Article

    Janku, F.; Zhang, H. H.; Pezeshki, A.; Goel, S.; Murthy, R.; Wang-Gillam, A.; Shepard, D. R.; Helgason, T.; Masters, T.; Hong, D. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study
    Journal Article

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Designing evolutionary-based interception strategies to block the transition from precursor phases to multiple myeloma
    Review

    Maura, F.; Landgren, O.; Morgan, G. J.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
    Journal Article

    Tannir, N. M.; Signoretti, S.; Choueiri, T. K.; McDermott, D. F.; Motzer, R. J.; Flaifel, A.; Pignon, J. C.; Ficial, M.; Frontera, O. A.; George, S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
    Journal Article

    Geistlinger, L.; Oh, S.; Ramos, M.; Schiffer, L.; LaRue, R. S.; Henzler, C. M.; Munro, S. A.; Daughters, C.; Nelson, A. C.; Winterhoff, B. J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk
    Meeting Abstract

    Zhu, J.; Shu, X.; Guo, X.; Liu, D.; Bao, J.; Milne, R.; Giles, G. G.; Wu, C.; Du, M.; White, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study
    Meeting Abstract

    Yarchoan, M.; Cope, L.; Anders, R. A.; Noonan, A.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A.; He, A. R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
    Meeting Abstract

    Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
    Meeting Abstract

    Zhang, Z.; Zhou, C.; Li, X.; Barnes, S.; Deng, S.; Hoover, E.; Chen, C. C.; Lee, Y. S.; Wang, C.; Tirado, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: